Qualtrics Survey | Qualtrics Experience Management
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
Please do this 5-minute survey which asks how you feel about people who use cannabis: qualtrics.kcl.ac.uk/jfe/form/SV_...
One of my excellent undergraduate research project students has designed the study, and needs more participants. Thanks!!
Fully anonymous. No payment.
05.01.2026 10:23 β π 1 π 2 π¬ 1 π 0
Thanks Janet. I emailed a few times without a reply earlier in the year. I've since got a response saying your team will investigate it, alongside the council & highways team - thank you. I also look forward to discussing it at the constituent meeting on 26th September.
08.09.2025 20:49 β π 0 π 0 π¬ 0 π 0
We have published our new review 'Recent Innovations to Detect and Intervene to Prevent Opioid Overdose Deaths' led by Basak Tas and John Strang.
kclpure.kcl.ac.uk/portal/en/pu...
02.07.2025 10:12 β π 5 π 1 π¬ 0 π 0
Quitting weed, in teenagers and young adults, is associated with dramatic drops in psychotic-like symptoms and depression.
All LMM analyses adjusted for relevant. genetic and environmental factors.
Publication expected later this year.
01.07.2025 08:25 β π 0 π 0 π¬ 0 π 0
Top-line findings: (1) cannabis use frequency predicts CUD, psychotic-like symptoms, and depression, (2) teenagers have persistently higher CUD severity, (3) additively, using cannabis frequently and being a teenager leads to highest psychotic-like symptom severity.
01.07.2025 08:25 β π 1 π 0 π¬ 1 π 0
Four-year trajectories of mental health symptoms in adolescents and adults who do and do not use cannabis
Hosted on the Open Science Framework
See our 4-year longitudinal CannTeen findings in our pre-print here: osf.io/8hmy9/
Joint first authors: Ayse Doga Lamper and Layla Sadek.
01.07.2025 08:25 β π 4 π 0 π¬ 1 π 0
These ongoing collaborations with secondary schools are highly rewarding as I am able to deliver important, scientific, health-related information directly to adolescents and subsequently recruit teenage participants into research studies about substance use.
30.06.2025 07:37 β π 1 π 0 π¬ 0 π 0
The London Drugs Commission 2025 report and the WHO 2024 report both called for improved cannabis and drugs education for adolescents. Hopefully my credible, cannabis-specific assemblies can be a very small part of this.
www.london.gov.uk/programmes-s...
onlinelibrary.wiley.com/doi/full/10....
30.06.2025 07:37 β π 1 π 0 π¬ 1 π 0
The new RA will deliver many more assemblies across the South East and make assembly materials openly and freely available online for all other UK schools to use.
30.06.2025 07:37 β π 0 π 0 π¬ 1 π 0
Pleased to say that I've been awarded a small Impact Acceleration grant to scale up my cannabis education school assemblies and explore their acceptability and short-term impact on early-mid adolescents.
30.06.2025 07:37 β π 4 π 0 π¬ 2 π 0
We analysed data from the KARE trial (n=96) to examine ketamineβs (0.8mg/kg infusion) psychoactive effects in alcohol use disorder and whether they mediate treatment response.
Drug effects were strong and mainly onsistent across 3 infusions, but did not mediate reduced drinking.
osf.io/kbswd
27.06.2025 08:35 β π 5 π 2 π¬ 0 π 0
The London Drugs Commission report on cannabis makes several recommendations which I support. We must (1) deliver research-informed cannabis education to *early* adolescents, (2) offer evidence-based, specialist treatment for CUD to youth and adults. www.london.gov.uk/programmes-s...
11.06.2025 09:10 β π 2 π 1 π¬ 0 π 0
Enjoyed presenting at #SOBP2025 on a #cannabis symposium organised by @emesekroon.bsky.social & @jcousijn.bsky.social. I presented 4-year longitudinal CannTeen data: teens who quit cannabis have reduced psychotic-like symptoms, and over 4 yrs teens are > sensitive to impact of frequent C use on CUD.
24.04.2025 20:46 β π 3 π 2 π¬ 0 π 0
I've been asked why negative effects might happen in universal school MH interventions, so going to share thoughts here. Short answer is we don't know, but there are multiple (not mutually exclusive) possibilities:
(thread)
26.02.2025 15:12 β π 16 π 5 π¬ 2 π 2
And if Sentia did produce GABA-induced anxiolytic effects, might it not be a relapse-promoting risk for those who are trying to completely abstain from alcohol?
25.02.2025 13:13 β π 1 π 1 π¬ 1 π 0
Instead, they report EEG results from a small open label study. The levels of GABA altering chemicals, first pass metabolism, bioabsorption, and ED50s for real subjective effects don't check out. It's misleading branding and poor science.
25.02.2025 13:13 β π 4 π 1 π¬ 2 π 0
Better than some articles but still too generous! Sentia is very expensive. Noone I know who has tried it thinks it has made them more relaxed (inc me). The creators of Sentia could easily do a blinded experiment on subjective effects, but don't.
25.02.2025 13:13 β π 2 π 1 π¬ 3 π 0
Generation K: The disturbing rise of ketamine abuse among young people
Increasing numbers of young people are using the drug, experts say. The health impacts can be catastrophic.
We need to better understand ketamine use in YP. And we need to improve prevention of and treatment for problem ketamine use. But when you read stories like this www.bbc.co.uk/news/article... you would think all YP are doing k. SDD in YP shows 0.4% 14-yos & 2.5% of 15-yos have used k in past yr.
25.02.2025 10:52 β π 0 π 0 π¬ 0 π 0
Credit to Dr Basak Tas and Sir John Strang for this important and challenging work which I had the privilege of being involved with. This study demonstrates the feasibility of the lab model of OD. More work needed to really explore impact of dose on respiratory depression @kingsioppn.bsky.social
15.02.2025 17:44 β π 1 π 1 π¬ 0 π 0
Project ADDER: Impact evaluation
The long-awaited evaluation of Project ADDER is now out, and makes fascinating reading for all with a concern for illicit drug problems in England and Wales. A thread: 1/? ttps://www.gov.uk/government/publications/project-adder-impact-evaluation/project-adder-impact-evaluation#key-findings
13.02.2025 13:23 β π 25 π 22 π¬ 3 π 4
Dr Basak Tas has published her important experimental work investigating the respiratory depressant effects of diamorphine in people with OUD. She increased dose of drug by 10 & 20% and measured respiratory function, in n=4. Honoured to be a part of this work.
onlinelibrary.wiley.com/doi/10.1111/...
11.02.2025 16:35 β π 1 π 2 π¬ 0 π 0
It refers to the correlation between brain activity and strength of preference for buying the reward. A parametric neural correlate of 'I really want it and I will pay lots for it'.
11.02.2025 15:24 β π 0 π 0 π¬ 1 π 0
Really interesting work, thank you. Do you mind sharing why you think we see these negative consequences of these whole school interventions? (I'm sure you cover this well in your papers, bit I'm a bit lazy sorry!!!)
11.02.2025 09:36 β π 3 π 0 π¬ 2 π 0
Thanks to co-authors: Xuejun Hao, Paul Glimcher, Margaret Haney, Anna Konova, Ziva Cooper, Nicholas van Dam
11.02.2025 08:47 β π 0 π 0 π¬ 0 π 0
More research needed now with a control group of people who drugs infrequently and without problems, to clearly explore the relationships between problematic use and value signals of drugs and non-drug rewards.
11.02.2025 08:47 β π 0 π 0 π¬ 1 π 0
The paper also demonstrates the feasibility of neuroeconomic research with illicit drugs.
11.02.2025 08:47 β π 0 π 0 π¬ 1 π 0
These results have relevance for neurobehavioural theories of #SUD which postulate that SUDs are caused by altered valuation of drugs and non-drug rewards. I'm cautious to conclude much about non-drug reward processing here, but value signals for drugs look fairly normal.
11.02.2025 08:47 β π 0 π 0 π¬ 1 π 0
Cannabis value signals were detected in key reward and valuation brain regions. Much to our surprise, snack food value signals and the impact of powerful cues showed unexpected patterns of results.
11.02.2025 08:47 β π 0 π 0 π¬ 1 π 0
n=20 participants. Crossover design. 4 sessions per participant, 2 factors: reward (cannabis/snack) and stimuli (neutral/active cues).
11.02.2025 08:47 β π 0 π 0 π¬ 1 π 0
Brenda Dacres, Directly Elected Mayor of the London Borough of Lewisham (Labour and Co-operative Party). Vice Chair of Central London Forward. Member (Labour) of LGA Public Sector Reform Board. Chair of London Council Transport & Environment Committee.
Labour and Co-op Party MP for Lewisham East.
Professor of Developmental Psychology at Ulster Uni.
Research group at Erasmus University Rotterdam, headed by PI Dr. Janna Cousijn, focussed on the effects of substance use and addiction on the brain.
https://nofaresearch.com
Postdoctoral Fellow in Psychiatry
Weill Cornell Medicine
An Academic Health Sciences Centre bringing together three NHS Foundation Trusts and a world-leading university, to translate early scientific research, discoveries, and ideas to benefit patients and communities.
π https://www.kingshealthpartners.org
Lecturer in Anthropology @SOASanthro | Sensing Others (2023) | Language, science, palms & Cold War environmental politics π΄πΏπ±
Professor of Psychology, @sheffielduni.bsky.social.
Addiction science: alcohol, gambling, decision-making, behaviour change, treatment. Also: π΄ββοΈ, Peak District
Neuroscience Postdoc Researcher @ IoPPN, King's College London
Professor of Neuroscience at King's College London. Passionate about teaching and researching ADHD. National Teaching Fellow and Principal Fellow of HEA/AdvanceHE.
Runner and greyhound lover.
All views are my own.
Lecturer and researcher in Developmental Psychology & CEDI in Higher Education. Views are mostly self-deprecating & definitely my own (He/Him)
Physical activity & mental health, exercise, sport, rule 62
PhD Candidate in Psychological Medicine at @kingsedresearch.bsky.social, researching eating disorder clinicians' experiences in the NHS.
Professor of social and psychiatric epidemiology at IOPPN, KCL, and psychiatrist. Co-Director of a UKRI national consortium on improving population mental health (PHIUK).
Pain and neurodiversity in rheumatoid arthritis @NeuroImmunePhD @KingsCollegeLon
Neuroscience MSc @UniHeidelberg
Neuroscience BSc @UWMadison
Interested in how the physical and social environment and climate change interacts with mental health... and a bit of implementation. PhD Student at #IoPPN looking at air pollution
Cell biologist. Interested in neurons, intracellular trafficking, ageing, and other things. Posting mainly about science.
www.vagnonilab.com
Research Assistant at @kingsioppn.bsky.social exploring remote technology in the study of cardiometabolic risk factors and medication adherence in adults with ADHD. Interests in neurodevelopmental disorders and digital health interventions.
Clinical Senior Lecturer and Consultant Psychiatrist at King's College London and South London and Maudsley NHS Foundation Trust